header

Carboplatin/gemcitabine as first line treatment of metastatic triple negative breast cancer / (Record no. 56504)

MARC details
000 -LEADER
fixed length control field 02448cam a2200325 a 4500
003 - CONTROL NUMBER IDENTIFIER
control field EG-GiCUC
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 160517s2015 ua dh f m 000 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency EG-GiCUC
Language of cataloging eng
Transcribing agency EG-GiCUC
041 0# - LANGUAGE CODE
Language code of text/sound track or separate title eng
049 ## - LOCAL HOLDINGS (OCLC)
Holding library Deposite
097 ## - Thesis Degree
Thesis Level Ph.D
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC)
Classification number Cai01.11.23.Ph.D.2015.Ah.C
100 0# - MAIN ENTRY--PERSONAL NAME
Personal name Ahmad Mahrous Dewidar
245 10 - TITLE STATEMENT
Title Carboplatin/gemcitabine as first line treatment of metastatic triple negative breast cancer /
Statement of responsibility, etc. Ahmad Mahrous Dewidar ; Supervised Mohammad Ahmad Hassan , Mohammad Sayed Abdelkader , Wael Samir Makar
246 15 - VARYING FORM OF TITLE
Title proper/short title علاج سرطان الثدي السلبي الثلاثي المنتشر باستخدام عقاري الجيمسيتابين/كاربوبلاتين كخط علاج أول
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Cairo :
Name of publisher, distributor, etc. Ahmad Mahrous Dewidar ,
Date of publication, distribution, etc. 2015
300 ## - PHYSICAL DESCRIPTION
Extent 72 P. :
Other physical details charts , facsimiles ;
Dimensions 25cm
502 ## - DISSERTATION NOTE
Dissertation note Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Oncology (clinical)
520 ## - SUMMARY, ETC.
Summary, etc. Background and objectives: Triple-negative breast cancer is regarded as an aggressive disease for which effective targeted therapy is not yet available. Results: Among the 34 included patients , 33 were considered valuable for response as one patient refused to continue treatment after she received the first week of treatment due to grade 3 vomiting, four patients (12.1%) achieved complete response and 20 patients (60.6%) had a partial response giving an overall response rate of 72.7% (95% CI, 60%-84%), one patients(3%) had stable disease > 6 months giving clinical benefit rate(CBR) of 75.7% (25/٣٣). The median duration of response of 6.5 months. while 8 cases progressed in treatment (24.7%), Median progression-free survival, was 6.18 months (95% CI 5.61{u2013}7·30 ) .Overall survival was 12.7month (range2-24, SD: 5.1) . Neutropenia G3 in 3 patients(9%) one of them developed febrile neutropenia ,anemia grade three in 4\33 patients(12%), thrombocytopenia grade 3 in 5 patinets (15%). Conclusions:. This study suggested that The combination was efficacious and well tolerated  
530 ## - ADDITIONAL PHYSICAL FORM AVAILABLE NOTE
Additional physical form available note Issued also as CD
653 #4 - INDEX TERM--UNCONTROLLED
Uncontrolled term Breast cancer
653 #4 - INDEX TERM--UNCONTROLLED
Uncontrolled term Metastatic
653 #4 - INDEX TERM--UNCONTROLLED
Uncontrolled term Triple negative
700 0# - ADDED ENTRY--PERSONAL NAME
Personal name Mohammad Ahmad Hassan ,
Relator term
700 0# - ADDED ENTRY--PERSONAL NAME
Personal name Mohammad Sayed Abdelkader ,
Relator term
700 0# - ADDED ENTRY--PERSONAL NAME
Personal name Wael Samir Makar ,
Relator term
905 ## - LOCAL DATA ELEMENT E, LDE (RLIN)
Cataloger Nazla
Reviser Revisor
905 ## - LOCAL DATA ELEMENT E, LDE (RLIN)
Cataloger Soheir
Reviser Cataloger
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Koha item type Thesis
Holdings
Source of classification or shelving scheme Not for loan Home library Current library Date acquired Full call number Barcode Date last seen Koha item type Copy number
Dewey Decimal Classification   المكتبة المركزبة الجديدة - جامعة القاهرة قاعة الرسائل الجامعية - الدور الاول 11.02.2024 Cai01.11.23.Ph.D.2015.Ah.C 01010110068873000 22.09.2023 Thesis  
Dewey Decimal Classification   المكتبة المركزبة الجديدة - جامعة القاهرة مخـــزن الرســائل الجـــامعية - البدروم 11.02.2024 Cai01.11.23.Ph.D.2015.Ah.C 01020110068873000 22.09.2023 CD - Rom 68873.CD